To search news releases, please click here.
Popular search terms:
Search Results
207 results found-
CSL Behring provides protein-based and recombinant therapies for bleeding disorders, immune deficiencies, hereditary angioedema and Alpha 1 antitrypsin deficiency, among others.
https://www.cslbehring.com/products/global-products-list -
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com/products -
CSL Behring supports Material Transfer (MT) of post-approval product in limited quantity via the Material Transfer Agreement (MTA).
https://www.cslbehring.com/r-and-d/material-transfers -
The CSL Behring products listed are covered by one or more patents in the United States and/or other countries.
https://www.cslbehring.com/products/patents -
CSL Behring's only US manufacturing plant is located in Kankakee, Illinois and employs more than 1,400 people.
https://www.cslbehring.com/our-company/kankakee-manufacturing-site -
CSL Behring offers an array of therapeutic support programs. We are here to help. Learn more today.
https://www.cslbehring.com/patients/support-and-assistance -
CSL Behring's Support and Assistance Programs
https://www.cslbehring.com/patients/support-and-assistance/copay-terms-and-conditions -
For support with product orders: 800-683-1288 / customersupport@cslbehring.com. Plasma donors should visit: cslplasma.com/contact-us.
https://www.cslbehring.com/contact/customer-support -
Social Media Community Guidelines for CSL Behring Corporate Channels
https://www.cslbehring.com/social-guidelines -
U.S. authorities say millions of Pine-Sol cleaning products could contain bacteria dangerous to those with weakened immune systems.
https://www.cslbehring.com/vita/2022/a-product-recall-alert-for-immunocompromised-patients